Remote Symptom Monitoring With Electronic Patient-Reported Outcomes in Clinical Cancer Populations.

ABSTRACT:

Importance

Value-based health care increasingly requires electronic patient-reported outcome-based remote symptom monitoring (RSM) to improve health care utilization in patients with cancer. However, data on the impact of RSM in clinical practice are lacking.

Objective

To evaluate the association of RSM with 3- and 6-month health care utilization among patients receiving systemic cancer treatment.

Design, setting, and participants

This nonrandomized controlled trial used a hybrid, type 2 implementation-effectiveness design. Participants were patients with cancer at 2 Alabama-based academic institutions receiving chemotherapy, targeted therapy, or immunotherapy; the exposure group received standard-of-care delivered RSM from 2021 to 2024, and historical controls were p

SUBMITTER: Rocque GB 

PROVIDER: S-EPMC12076171 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature